Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Sci Rep ; 8(1): 8250, 2018 May 23.
Article in English | MEDLINE | ID: mdl-29789675

ABSTRACT

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

2.
Sci Rep ; 8(1): 5016, 2018 03 22.
Article in English | MEDLINE | ID: mdl-29567948

ABSTRACT

The rpoB gene encodes the ß subunit of RNA polymerase holoenzyme in Mycobacterium leprae (M. leprae). Missense mutations in the rpoB gene were identified as etiological factors for rifampin resistance in leprosy. In the present study, we identified mutations corresponding to rifampin resistance in relapsed leprosy cases from three hospitals in southern India which treat leprosy patients. DNA was extracted from skin biopsies of 35 relapse/multidrug therapy non-respondent leprosy cases, and PCR was performed to amplify the 276 bp rifampin resistance-determining region of the rpoB gene. PCR products were sequenced, and mutations were identified in four out of the 35 cases at codon positions D441Y, D441V, S437L and H476R. The structural and functional effects of these mutations were assessed in the context of three-dimensional comparative models of wild-type and mutant M. leprae RNA polymerase holoenzyme (RNAP), based on the recently solved crystal structures of RNAP of Mycobacterium tuberculosis, containing a synthetic nucleic acid scaffold and rifampin. The resistance mutations were observed to alter the hydrogen-bonding and hydrophobic interactions of rifampin and the 5' ribonucleotide of the growing RNA transcript. This study demonstrates that rifampin-resistant strains of M. leprae among leprosy patients in southern India are likely to arise from mutations that affect the drug-binding site and stability of RNAP.


Subject(s)
Bacterial Proteins/genetics , DNA-Directed RNA Polymerases/genetics , Drug Resistance, Bacterial/genetics , Leprostatic Agents/pharmacology , Leprosy/drug therapy , Mycobacterium leprae/genetics , Rifampin/pharmacology , Adolescent , Adult , DNA, Bacterial/genetics , Female , Humans , India , Leprostatic Agents/therapeutic use , Leprosy/microbiology , Male , Microbial Sensitivity Tests , Middle Aged , Mutation , Mycobacterium leprae/drug effects , Mycobacterium leprae/isolation & purification , Protein Binding/genetics , Protein Stability/drug effects , Recurrence , Rifampin/therapeutic use , Sequence Analysis, DNA , Structure-Activity Relationship , Treatment Outcome , Young Adult
3.
Int. j. lepr. other mycobact. dis ; 70(4): 245-249, Dec., 2002. ilus, tab
Article in English | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1227120

ABSTRACT

The role of dosage of Mycobacterium leprae and the environment of the inoculated site, in producing leprosy lesions in immunologically-suppressed, highly-susceptible T900r mice, was investigated. Various doses of M. leprae, i.e., 10(7), 10(6), 10(5), 10(4), were inoculated into both flanks and footpads of two different groups of mice. The sites of inoculation were biopsied for histopathological examination and for M. leprae counts at the end of 6, 8 and 12 months. M. leprae multiplied at the infected site and disseminated [figure: see text] to other parts of the body at all concentrations in the mice that were infected in the footpad with a temperature of 31 degrees C. In animals inoculated at the flanks with a temperature of 37 degrees C, multiplication was recorded only when the dosage of M. leprae was high and there was no dissemination of the organism in any of them. The temperature at the site of entry and the dose of infecting M. leprae may play an important role in the development of leprosy in susceptible individuals exposed to M. leprae.


Subject(s)
Animals , Mice , Leprosy/immunology , Mycobacterium leprae/physiology , Mycobacterium leprae/immunology
4.
Int J Lepr Other Mycobact Dis ; 70(4): 245-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12768925

ABSTRACT

The role of dosage of Mycobacterium leprae and the environment of the inoculated site, in producing leprosy lesions in immunologically-suppressed, highly-susceptible T900r mice, was investigated. Various doses of M. leprae, i.e., 10(7), 10(6), 10(5), 10(4), were inoculated into both flanks and footpads of two different groups of mice. The sites of inoculation were biopsied for histopathological examination and for M. leprae counts at the end of 6, 8 and 12 months. M. leprae multiplied at the infected site and disseminated [figure: see text] to other parts of the body at all concentrations in the mice that were infected in the footpad with a temperature of 31 degrees C. In animals inoculated at the flanks with a temperature of 37 degrees C, multiplication was recorded only when the dosage of M. leprae was high and there was no dissemination of the organism in any of them. The temperature at the site of entry and the dose of infecting M. leprae may play an important role in the development of leprosy in susceptible individuals exposed to M. leprae.


Subject(s)
Abdomen/microbiology , Foot/microbiology , Leprosy/microbiology , Mycobacterium leprae/physiology , Mycobacterium leprae/pathogenicity , Animals , Colony Count, Microbial , Disease Models, Animal , Immunosuppression Therapy , Leprosy/physiopathology , Mice , Mice, Inbred CBA , Skin/microbiology , Thymectomy , Whole-Body Irradiation
5.
Int. j. lepr. other mycobact. dis ; 67(2): 162-164, Jun., 1999. ilus, tab
Article in English | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1226870
SELECTION OF CITATIONS
SEARCH DETAIL